share_log

Lake Street Maintains Buy on Checkpoint Therapeutics, Lowers Price Target to $14

Lake Street Maintains Buy on Checkpoint Therapeutics, Lowers Price Target to $14

Lake Street 维持对 Checkpoint Therapeutics 的买入,将目标
Benzinga ·  2023/08/16 13:08

Lake Street analyst Thomas Flaten maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and lowers the price target from $16 to $14.

Lake Street分析师托马斯·弗拉滕维持Checkpoint Therapeutics(纳斯达克股票代码:CKPT)的买入,并将目标股价从16美元下调至14美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发